Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study - Thorand, B; Zierer, A; Huth, C (Diabetes Care, 2011)
et al.